MB21D2 Activators constitute a specialized group of chemical entities designed to selectively engage and modulate the activity of MB21D2, also known as cGAS (cyclic GMP-AMP synthase). cGAS is a cytosolic DNA sensor that plays a pivotal role in the innate immune response by detecting microbial and self-DNA in the cytoplasm and initiating a signaling cascade that leads to the production of type I interferons and other cytokines. The activators of MB21D2/cGAS are synthesized through intricate chemical processes, aiming to enhance the enzyme's ability to synthesize cyclic GMP-AMP (cGAMP), a second messenger that activates the STING pathway, crucial for the immune response. These compounds are meticulously engineered to bind to MB21D2/cGAS, potentially altering its conformation to stimulate its enzymatic activity. The design of MB21D2 Activators involves a deep understanding of the enzyme's structure, active site, and the molecular dynamics that govern its interaction with DNA and subsequent catalytic activity. These activators are characterized by their specificity to MB21D2/cGAS and their ability to modulate its function without adversely affecting other cellular processes.
The research into MB21D2 Activators is highly interdisciplinary, combining elements of immunology, biochemistry, and structural biology. Scientists employ a variety of experimental techniques to investigate the interaction between these activators and MB21D2/cGAS, including X-ray crystallography and cryo-electron microscopy for structural elucidation, as well as various biochemical assays to measure enzyme activity and the production of cGAMP. Computational approaches, such as molecular docking and dynamics simulations, are also pivotal in predicting how activators might interact with the enzyme and influence its activity. This research not only enhances our understanding of the innate immune response at the molecular level but also contributes to the broader field of enzymology by elucidating how small molecule activators can modulate enzyme function. Through the study of MB21D2 Activators, scientists aim to gain insights into the mechanisms by which cellular sensors like cGAS detect and respond to DNA, furthering our understanding of cellular defense mechanisms and the regulation of immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
An immune response modifier that can enhance the expression of various genes related to the innate immune system. | ||||||
DMXAA | 117570-53-3 | sc-207592 sc-207592A | 5 mg 25 mg | $129.00 $590.00 | 1 | |
A vascular disrupting agent that can also stimulate innate immune responses, potentially upregulating MB21D2. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
An agonist of toll-like receptors that can influence the expression of genes in the innate immune pathway. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A selective TLR7 agonist that might activate immune response signaling pathways and affect MB21D2. | ||||||